Mayo Clinic Proceedings Home

Incidence of Type 1 Diabetes Is Not Increasing in a Population-Based Cohort in Olmsted County, Minnesota, USA



      To investigate the recent incidence of T1D in a US Midwestern county to determine whether this increase has been sustained and compare it with the incidence of celiac disease (CD) and also investigate the prevalence of CD, an associated autoimmune disease, within the cohort.

      Patients and Methods

      A broad search strategy was used to identify all incident cases of T1D in Olmsted County, Minnesota, between January 1, 1994, and December 31, 2010, using the Rochester Epidemiology Project. Diagnosis and residency status were confirmed through the medical record. Incidence rates were directly standardized to the 2010 US population. Poisson regression was used to test for a change in incidence rate. Clinical charts were reviewed to confirm case status.


      There were 233 incident cases of T1D. Directly adjusting for age and sex with respect to the 2010 US white population, the overall annual incidence of T1D was 9.2 (95% CI, 8.0-10.4) per 100,000 people per year among all ages and 19.9 (95% CI, 16.6-23.2) per 100,000 people per year for those younger than 20 years. There was no significant increase in the incidence of T1D over time (P=.45). Despite the overall stability in annual incidence, there was an initial increasing trend followed by a plateau. Of the 109 patients with T1D (47%) tested for CD, 12% (13) had biopsy-proven CD.


      The incidence of T1D has stopped increasing in Olmsted County, Minnesota, in the most recent decade. Further studies are needed to confirm this finding and explore reasons for this plateau.

      Abbreviations and Acronyms:

      CD (celiac disease), LADA (latent autoimmune diabetes in adults), REP (Rochester Epidemiology Project), T1D (type 1 diabetes), T2D (type 2 diabetes)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Borchers A.T.
        • Uibo R.
        • Gershwin M.E.
        The geoepidemiology of type 1 diabetes.
        Autoimmun Rev. 2010; 9: A355-A365
        • Rawshani A.
        • Landin-Olsson M.
        • Svensson A.M.
        • et al.
        The incidence of diabetes among 0-34 year olds in Sweden: new data and better methods.
        Diabetologia. 2014; 57: 1375-1381
        • Zhao Z.
        • Sun C.
        • Wang C.
        Rapidly rising incidence of childhood type 1 diabetes in Chinese population: epidemiology in Shanghai during 1997-2011.
        Acta Diabetol. 2014; 51: 947-953
        • Berhan Y.
        • Waernbaum I.
        • Lind T.
        • Mollsten A.
        • Dahlquist G.
        • Swedish Childhood Diabetes Study Group
        Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden.
        Diabetes. 2011; 60: 577-581
        • Patterson C.C.
        • Dahlquist G.G.
        • Gyürüs E.
        • Green A.
        • Soltész G.
        • EURODIAB Study Group
        Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study.
        Lancet. 2009; 373: 2027-2033
        • Bendas A.
        • Rothe U.
        • Kiess W.
        • et al.
        Trends in incidence rates during 1999-2008 and prevalence in 2008 of childhood type 1 diabetes mellitus in Germany—model-based national estimates.
        PLoS One. 2015; 10: e0132716
        • Lawrence J.M.
        • Imperatore G.
        • Dabelea D.
        • SEARCH for Diabetes in Youth Study Group
        Trends in incidence of type 1 diabetes among non-Hispanic white youth in the US, 2002-2009.
        Diabetes. 2014; 63: 3938-3945
        • Hober D.
        • Sauter P.
        Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host.
        Nat Rev Endocrinol. 2010; 6: 279-289
        • Stene L.C.
        • Gale E.A.
        The prenatal environment and type 1 diabetes.
        Diabetologia. 2013; 56: 1888-1897
        • Mäkinen M.
        • Simell V.
        • Mykkänen J.
        • et al.
        An increase in serum 25-hydroxyvitamin D concentrations preceded a plateau in type 1 diabetes incidence.
        J Clin Endocinol Metab. 2014; 99: E2353-E2356
        • Beyerlein A.
        • Chmiel R.
        • Hummel S.
        • Winkler C.
        • Bonifacio E.
        • Ziegler A.G.
        Timing of gluten introduction and islet autoimmunity in young children: updated results from the BABYDIET study.
        Diabetes Care. 2014; 37: e194-e195
        • Norris J.M.
        • Barriga K.
        • Hoffenberg E.J.
        • et al.
        Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease.
        JAMA. 2005; 293: 2343-2351
        • Mahmud F.H.
        • Murray J.A.
        • Kudwa Y.C.
        • et al.
        Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features.
        Mayo Clin Proc. 2005; 80: 1429-1434
        • Elfström P.
        • Sundström J.
        • Ludvigsson J.F.
        Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes.
        Aliment Pharmacol Ther. 2014; 40: 1123-1132
        • Gillett P.M.
        • Gillett H.R.
        • Israel D.M.
        • et al.
        High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase.
        Can J Gastroenterol. 2001; 15: 297-301
        • Murray J.A.
        • Van Dyke C.
        • Plevak M.F.
        • Dierkhising R.A.
        • Zinsmeister A.R.
        • Melton III, L.J.
        Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001.
        Clin Gastroenterol Hepatol. 2003; 1: 19-27
        • Ludvigsson J.F.
        • Rubio-Tapia A.
        • Van Dyke C.T.
        • et al.
        Increasing incidence of celiac disease in a North American population.
        Am J Gastroenterol. 2013; 108: 818-824
      1. Korponay-Szabo IR, Szabados K, Pusztai J, et al. Primary prevention of type 1 diabetes mellitus by celiac mass screening in children. Oral Presentation. International Celiac Disease Symposium 2015. Prague, CZK. June 23, 2015.

        • Rocca W.A.
        • Yawn B.P.
        • St Sauver J.L.
        • Grossardt B.R.
        • Melton III, L.J.
        History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.
        Mayo Clin Proc. 2012; 87: 1202-1213
      2. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
        Diabetes Care. 2010; 33: S62-S69
        • Dyck P.J.
        • Kratz K.M.
        • Lehman K.A.
        • et al.
        The Rochester Diabetic Neuropathy Study: design criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests.
        Neurology. 1991; 41: 799-807
        • Kovatchev B.P.
        • Otoo E.
        • Cox D.
        • Gonder-Frederick L.
        • Clarke W.
        Evaluation of a new measure of blood glucose variability in diabetes.
        Diabetes Care. 2006; 29: 2433-2438
        • Irvine W.J.
        • Gray R.S.
        • McCallum C.J.
        Pancreatic islet-cell antibody as a marker for asymptomatic and latent diabetes and prediabetes.
        Lancet. 1976; 2: 1097-1102
        • Andersen M.K.
        • Lundgre V.
        • Turunen J.A.
        • et al.
        Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years.
        Diabetes Care. 2010; 33: 2062-2064
        • Pipi E.
        • Maretou M.
        • Tsirogianni A.
        Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus.
        World J Diabetes. 2014; 5: 505-510
        • Rubio-Tapia A.
        • Hill I.D.
        • Kelly C.P.
        • Calderwood A.H.
        • Murray J.A.
        ACG clinical guidelines: Diagnosis and management of celiac disease.
        Am J Gastroenterol. 2013; 108: 656-676
        • Larsen J.
        • Weile C.
        • Antvorskov J.C.
        • et al.
        Effect of dietary gluten on dendritic cells and innate immune subsets in BALB/c and NOD mice.
        PLoS One. 2015; 10: e0118618
        • Hadley D.
        • Hagopian W.
        • Liu E.
        • et al.
        • TEDDY Study Group
        HLA-DPB1*04:01 protects genetically susceptible children from celiac disease autoimmunity in the TEDDY study.
        Am J Gastroenterol. 2015; 110: 915-920
        • Smigoc Schweiger D.
        • Mendez A.
        • Kunilo Jamnik S.
        • et al.
        Genetic risk for co-occurrence of type 1 diabetes and celiac disease is modified by HLA-C and killer immunoglobulin-like receptors.
        Tissue Antigens. 2015; 84: 471-478
        • Adlercreutz E.H.
        • Wingren C.J.
        • Vincente R.P.
        • Merlo J.
        • Agardh D.
        Perinatal risk factors increase the risk of being affected by both type 1 diabetes and coeliac disease.
        Acta Paediatr. 2015; 104: 178-184